Navigation Links
Guillermo Moreno Named Aurillion's Vice President of Sales and Marketing
Date:9/17/2008

Veteran healthcare executive brings solid experience with international

healthcare and technology companies

TORONTO, Sept. 17 /PRNewswire/ -- Aurillion, a leading provider of healthcare workflow management tools, announced the appointment of Guillermo Moreno as its vice president of sales and marketing. In this role, Moreno is responsible for developing and implementing strategic initiatives to grow the company's business throughout the Americas, Europe and Asia. He is based in the United States, and reports directly to Paul Gilmor, president and chief executive officer of Aurillion.

"We're excited to have Guillermo on our team as we continue to capitalize on our momentum of bringing self-service technologies to the healthcare arena," said Paul Gilmor, president and CEO of Aurillion. "Guillermo brings with him an insider's perspective and an impressive range of experience from every corner of the healthcare and high-tech marketplace. He's perfectly positioned to strengthen Aurillion's sales and marketing platforms as our company, and this industry, continues to grow."

Moreno, a 24-year veteran of the healthcare industry, spent the past 10 years in healthcare information technology (HIT) at Cerner Corporation, a multi billion dollar supplier of integrated HIT. At Cerner, he held a variety of roles with increasing responsibility in sales, marketing, operations and client development, resulting in appointment to vice president and general manager of its Latin America and Caribbean markets. Most recently, Moreno was a partner with a consulting organization focused on healthcare transformation in both Canada and the United States.

Moreno is a board member for the National Healthcare Information and Management Systems Society (HIMSS) Foundation, the president of the South Florida HIMSS Chapter and a board member of the Central/North Florida HIMSS Chapter. Moreno has participated and spoken at various national and international conferences and events on diverse subjects related to healthcare technology, including trends and global expansion. Guillermo has a master's degree in architecture from Texas A & M University with a specialization in hospital planning and design.

About Aurillion

Aurillion is a software company focused on the development of integrated, scalable healthcare information technologies and services to streamline patient workflows. Through a secure, self-service solution, Aurillion enables customers to achieve tangible, sustainable and financial outcomes that improve operational efficiencies and enhance the patient care experience within hospitals, clinics and other health organizations. Aurillion has offices in Mississauga and Toronto, Ontario.


'/>"/>
SOURCE Aurillion
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. NovaVision CEO Named Presenter at the AdvaMed 2008 Conference
2. Baxter Named to Dow Jones Sustainability Index for Tenth Consecutive Year
3. Expression Genetics EGEN-001 Named One of 10 Most Promising Oncology Products by Windhover
4. Concentric Named Professional Agency of Record for Discovery Labs SURFAXIN(R)
5. Stoppert Named as President and CEO at Breakthrough Renewable Technology Firm Segetis, Inc
6. Baxa Corporation Named to Inc. 5000 for Second Consecutive Year as One of the Fastest-Growing Private Companies in the US
7. IDIS Opens New American Office in Response to Industrys Growing Need for Pre-Launch Named Patient Programs
8. Integrated Project Management Named to "Inc. 5000" for Second Year : One of the Top 100 Fastest-Growing Companies in Chicago Area
9. Bill Pollock, President and CEO of Pharmagistics Group, Named to PharmaVOICE List of 100 Most Inspiring and Influential Leaders in the Life Sciences
10. CV Therapeutics Announces Ranexa(R) Named Finalist for Prix Galien USA 2008 Award
11. William F. Prendergast Named One of the Top IP Lawyers in Nanotechnology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... /PRNewswire -- WuXi AppTec, a leading global pharmaceutical, ... platform, today announced that it has acquired HD ... discovery contract research organization (CRO). After completion of ... of WuXi, and will continue to focus on ... The acquisition will further strengthen WuXi,s R&D capability ...
(Date:1/19/2017)... CALABASAS, Calif. , Jan. 19, 2017 /PRNewswire/ ... Mathias Schmidt , Ph.D., as chief executive ... board of directors. Dr. Schmidt brings to ArmaGen more ... on the research and development of biotherapeutics and ... biopharmaceutical executive with the diverse experience and skillset ...
(Date:1/19/2017)... , ... January 19, 2017 , ... ... with services spanning the full spectrum of drug and device development, and ... to pharma/device companies and clinicians, today announced Verified Clinical Trials (VCT) ...
(Date:1/18/2017)... ... January 18, 2017 , ... Opal ... using USB or PCI Express, announced the ZEM5310 USB 3.0 FPGA Module, combining ... a compact business-card sized form factor suitable for prototyping, testing, and production-ready integration. ...
Breaking Biology Technology:
(Date:1/19/2017)... , January 19, 2017 According to a new ... and Forecast, 2014 - 2022," the global biometric sensor market is expected to ... to 2022. In 2015, Asia-Pacific dominated the global market ... private sectors. Continue Reading ... ...
(Date:1/12/2017)... 12, 2017  Trovagene, Inc. (NASDAQ: TROV ... today announced that it has signed agreements with seven ... the Middle East for commercialization ... the first wave of international distribution agreements for Trovagene,s ... samples. The initial partners will introduce Trovagene,s ...
(Date:1/6/2017)... LA JOLLA, Calif. , Jan. 6, 2017 ... Phase 1 safety studies in healthy volunteers of ... CM4620, intended to treat acute pancreatitis. ... pancreas, is typically a mild disorder, but can ... to organ failure and sepsis, where extended hospital ...
Breaking Biology News(10 mins):